Increased serum levels of macrophage colony-stimulating factor in ovarian cancer
- 1 October 1991
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 165 (4) , 1356-1362
- https://doi.org/10.1016/s0002-9378(12)90761-9
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Circulating levels of CSF-1 (M-CSF) a lymphohematopoietic cytokine may be a useful marker of disease status in patients with malignant ovarian neoplasmsInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines.Journal of Clinical Investigation, 1989
- Intraclonal diversity of fibrosarcoma cells for the production of macrophage colony‐stimulating factor and granulocyte colony‐stimulating factorJournal of Cellular Physiology, 1987
- Macrophages specifically regulate the concentration of their own growth factor in the circulation.Proceedings of the National Academy of Sciences, 1987
- Expression of the macrophage specific colony-stimulating factor (CSF-1) during human monocytic differentiationBiochemical and Biophysical Research Communications, 1986
- Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancerNature, 1985
- Transforming protein of simian sarcoma virus stimulates autocrine growth of SSV-transformed cells through PDGF cell-surface receptorsCell, 1984
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981
- Methods for the purification, assay, characterization and target cell binding of a colony stimulating factor (CSF-1)Journal of Immunological Methods, 1981